Quintanilla, R. A., Jin, Y. N., Fuenzalida, K., Bronfman, M., & Johnson, G. V. W. (2008). Rosiglitazone Treatment Prevents Mitochondrial Dysfunction in Mutant Huntingtin-expressing Cells: POSSIBLE ROLE OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-γ (PPARγ) IN THE PATHOGENESIS OF HUNTINGTON DISEASE. American Society for Biochemistry and Molecular Biology.

Quintanilla, Rodrigo A., Youngnam N. Jin, Karen Fuenzalida, Miguel Bronfman, e Gail V. W. Johnson. Rosiglitazone Treatment Prevents Mitochondrial Dysfunction in Mutant Huntingtin-expressing Cells: POSSIBLE ROLE OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-γ (PPARγ) IN THE PATHOGENESIS OF HUNTINGTON DISEASE. American Society for Biochemistry and Molecular Biology, 2008.

Quintanilla, Rodrigo A., et al. Rosiglitazone Treatment Prevents Mitochondrial Dysfunction in Mutant Huntingtin-expressing Cells: POSSIBLE ROLE OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-γ (PPARγ) IN THE PATHOGENESIS OF HUNTINGTON DISEASE. American Society for Biochemistry and Molecular Biology, 2008.